Literature DB >> 18442121

Olfactory pathogenesis of idiopathic Parkinson disease revisited.

Alicja Lerner1, Anto Bagic.   

Abstract

Idiopathic Parkinson disease (PD) is traditionally considered a movement disorder with hallmark lesions located in the substantia nigra pars compacta (SNpc). However, recent histopathological studies of some PD cases suggest the possibility of a multisystem disorder which progresses in a predictable sequence as described in Braak's staging criteria. The disease process starts in the dorsal motor nucleus of the vagus (dmX) and anterior olfactory nucleus and bulb, and from there, spreads through the brainstem nuclei to ultimately reach the SNpc, which then presents as symptomatic PD. In this article, we would like to revisit the olfactory pathogenesis of PD based on Braak's staging system and review anatomical pathways supporting such a possibility. We also suggest some biomarkers for early stages of PD. Additionally, we present and discuss the possibility that a prion-like process underlies the neurodegenerative changes in PD. (c) 2008 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442121     DOI: 10.1002/mds.22066

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

Review 1.  Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.

Authors:  Trevor Tyson; Jennifer A Steiner; Patrik Brundin
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

2.  Inducible dopaminergic glutathione depletion in an α-synuclein transgenic mouse model results in age-related olfactory dysfunction.

Authors:  Y H Kim; S Lussier; A Rane; S W Choi; J K Andersen
Journal:  Neuroscience       Date:  2010-11-03       Impact factor: 3.590

3.  Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.

Authors:  James F Morley; Daniel Weintraub; Eugenia Mamikonyan; Paul J Moberg; Andrew D Siderowf; John E Duda
Journal:  Mov Disord       Date:  2011-05-24       Impact factor: 10.338

4.  Reduced Rapid Eye Movement Density in Parkinson Disease: A Polysomnography-Based Case-Control Study.

Authors:  Lynn A Schroeder; Olivier Rufra; Nicolas Sauvageot; François Fays; Vannina Pieri; Nico J Diederich
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

5.  Immunology, autoimmunity, and autoantibodies in Parkinson's disease.

Authors:  Michal Benkler; Nancy Agmon-Levin; Sharon Hassin-Baer; Oren S Cohen; Oscar-Danilo Ortega-Hernandez; Amalia Levy; Samuel-Datum Moscavitch; Martine Szyper-Kravitz; Maya Damianovich; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 6.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

7.  Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease.

Authors:  J Wang; H You; J-F Liu; D-F Ni; Z-X Zhang; J Guan
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

Review 8.  Early Parkinson's disease and non-motor issues.

Authors:  K Ray Chaudhuri; Yogini Naidu
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

9.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

10.  Expression of early growth response protein 1 in vasopressin neurones of the rat anterior olfactory nucleus following social odour exposure.

Authors:  Douglas W Wacker; Vicky A Tobin; Julia Noack; Valerie R Bishop; Adrian J Duszkiewicz; Mario Engelmann; Simone L Meddle; Mike Ludwig
Journal:  J Physiol       Date:  2010-10-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.